Dr. Gino Thamas Trevisani, MD

Dr. Trevisani practices at University of Vermont Medical Center in Burlington, Vermont, part of University of Vermont Health Network.

Dr. Trevisani's NPI, 1619912607, was assigned on June 17, 2006. Dr. Trevisani graduated from University of Vermont College of Medicine in 1991. Dr. Trevisani holds Vermont license 0420010341.

Dr. Trevisani's primary practice is University of Vermont Medical Center, at 111 Colchester Ave, Burlington, VT 05401 in Chittenden County. The practice phone is (802) 847-0000.

Dr. Trevisani's primary practice is University of Vermont Medical Center in Burlington, Vermont, part of University of Vermont Health Network. Dr. Trevisani is also affiliated with Northwestern Medical Center. The medical group on file is University of Vermont Medical Center. Dmand AI also links Dr. Trevisani to 1 more dialysis center, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Trevisani practices, 4 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Trevisani's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Trevisani is licensed in Vermont.

CMS data shows 316 Medicare services from Dr. Trevisani across 13 procedure codes in 2024, for 198 Medicare patients. Medicare paid $18,637 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 198 Medicare patients who saw Dr. Trevisani in 2024. The largest group is 65 to 74, with 80 patients. 73% of them have high blood pressure, and 68% have high cholesterol. 30% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Trevisani's median patient age at 64, with 52% women.

In 2024, Dr. Trevisani wrote 79 Medicare Part D claims for 38 patients. 85% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $33 in total drug cost. In 2018, CMS named 34 claims across 2 drugs.

Dr. Trevisani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 74 procedures of colonoscopy by Dr. Trevisani, more than 72% of the clinicians it reports for that procedure.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair - groin (open): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Trevisani, published from 2015 to 2024. Dr. Trevisani's most frequent co-authors are Karim Alavi, MD, Pamela L. Burgess, MD and Sandy H. Fang, MD.

Dmand AI links Dr. Trevisani to 1 clinical trial. Conditions studied include Fissure in Ano and Hemorrhoids.

CMS Open Payments shows 14 general payments to Dr. Trevisani from 5 drug and device companies from 2019 to 2025. Device or supply loans make up the largest share, 63% of the total. Integra LifeSciences Corporation paid the most, $1,157.

Dr. Trevisani graduated from University of Vermont College of Medicine in 1991.